Circio Holding ASA (STU:TA50) Cash Flow for Dividends : €0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Circio Holding ASA Cash Flow for Dividends?

Circio Holding ASA's cash flow for dividends for the six months ended in Dec. 2024 was €0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Circio Holding ASA Cash Flow for Dividends Historical Data

The historical data trend for Circio Holding ASA's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Circio Holding ASA Cash Flow for Dividends Chart

Circio Holding ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Dividends

Get a 7-Day Free Trial

Circio Holding ASA Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Circio Holding ASA Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Circio Holding ASA Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Circio Holding ASA's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Circio Holding ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circio Holding ASA (STU:TA50) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

CRNA:Norway 0RIS:UK TA50:Germany

Address

Saint Olavs plass, Pb. 6887, Oslo, NOR, 0130

Website

https://www.circio.com

Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients. The company's pipeline candidate includes circVec and Mutant KRAS.

Circio Holding ASA Headlines

No Headlines